Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients.

American journal of clinical oncology - 1 Apr 2020

Florindez Jorge, Trent Jonathan

Abstract excerpt

OBJECTIVE: The objective of this study was to determine whether there were survival differences associated with KIT mutation testing, type of KIT mutations, and other clinical variables in patients with localized or metastatic gastrointestinal tumor (GIST). METHODS: Adult patients with GIST were extracted from the Surveillance Epidemiology and End Results (SEER) database from 2010 to 2015 with follow-up through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over
Share to Gastrointestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Stromal Tumors

Share to Genetic Testing

Share to Proto-Oncogene Proteins c-kit

Share to United States

Share to Young Adult

Source

Identifiers

PMID: 31904710
DOI: 10.1097/COC.0000000000000659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients.PMID 31904710Read ↗

Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice.Semantic proximity Read ↗

Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study.Semantic proximity Read ↗

Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy.Semantic proximity Read ↗

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience.Semantic proximity Read ↗

Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients.Semantic proximity Read ↗

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).Semantic proximity Read ↗

Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis.Semantic proximity Read ↗

Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategiesSemantic proximity Read ↗

Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western GreeceSemantic proximity Read ↗

The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study.Semantic proximity Read ↗

Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity.Semantic proximity Read ↗

Targeted Therapy for Advanced Gastrointestinal Stromal Tumors: Evolution and Future Directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.